Disease Info Card

Neurobehavioral Manifestations

Information about Neurobehavioral Manifestations: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.

Overview of Neurobehavioral Manifestations

Most recent studies have shown that Neurobehavioral Manifestations shares some biological mechanisms with alzheimers-disease, anxiety-disorders, behavioral-symptoms, brain-injuries, cognition-disorders, dementia, depressive-disorder, depressive-symptom, impaired-cognition, impairment-(finding), major-depressive-disorder, malnutrition, memory-disorders, mental-disorders, nervousness, pain, parkinson-disease, psychiatric-symptom, psychotic-disorders, schizophrenia.

Among the many pathways, these few ones have gauged particular interests from scientists studying Neurobehavioral Manifestations, and have been seen in publications frequently: Aging, Brain Development, Cell Death, Cognition, Glycine Transport, Innervation, Localization, Locomotion, Long-term Memory, Menopause, Neurogenesis, Neuroprotection, Pathogenesis, Prepulse Inhibition, Reflex, Secretion, Short-term Memory, Synaptic Transmission, Translation, Transport

Quite a number of genes have been found to play important roles in Neurobehavioral Manifestations, such as ACHE, APOE, APP, BCHE, BDNF, CHRNA4, CSF2, DAO, DIO2, DRD2, FANCA, FXN, HTT, LAMC2, MAPT, PGPEP1, SGCA, SLC6A3, SLC6A9. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.

In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.